Ovarian Cancer Clinical Roundup

News Articles

(Yahoo! Finance) Oct 5, 2020 - First clinical study to combine ZEN-3694 with BMS’s immune checkpoint inhibitors nivolumab and ipilimumab for treatment of ovarian cancer.
(Karolinska Institutet [Sweden]) Sept 25, 2020 - Women receiving fertility-sparing surgery for treatment of borderline ovarian tumours were able to have children, a study from Karolinska Institutet in Sweden published in Fertility & Sterility shows.
View all ovarian cancer news

Case Studies

caseStudyImage

Dr. Slomovitz, Professor of Obstetrics and Gynecology, Florida International University, Gynecologic Oncologist, Broward Health, and Dr. Morrissey, Obstetrics and Gynecology and Women's Health Institute, Cleveland Clinic Weston, discuss high-grade serous ovarian cancer recurrence regarding surgery vs. chemotherapy

Clinical Briefs

PARP inhibition continues to steal the spotlight in advanced ovarian cancer, even in the absence of pivotal trial data. Findings presented at the European Society of Medical Oncology (ESMO) Virtual Congress 2020 showed a significant benefit for PARP inhibition earlier in the cancer pathway, offering hope for more long-term survivors, while other treatment paradigms such as immunotherapy failed again to make headway against the disease.

Featured Ovarian Cancer Tweets

Ronny I. Drapkin, MD, PhD
ronny_drapkin - Oct 09  Almost Half Of Patients With Newly Diagnosed BRCA-Mutated Advanced Ovarian Cancer May Be Progression-Free After Rec… https://t.co/EYTthAANx2

Nicole D. Flemming, MD
nicoleflemingmd - Oct 08  Congrats to ⁦@annafagottimd⁩ and co-authors on SCORPION trial in #ovariancancer with HIGH tumor burden demonstratin… https://t.co/9jpXv0Lyyi